Citation: Dp. Ryan et al., Phase I and pharmacokinetic study of esteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies, CLIN CANC R, 7(2), 2001, pp. 231-242
Authors:
Seiden, MV
Spitzer, TR
McAfee, S
Fuller, AF
Citation: Mv. Seiden et al., Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma, GYNECOL ONC, 83(2), 2001, pp. 412-414
Authors:
Penson, RT
Supko, JG
Seiden, MV
Fuller, AF
Berkowitz, RS
Goodman, A
Campos, SM
MacNeill, KM
Cook, S
Matulonis, UA
Citation: Rt. Penson et al., A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Mullerian tumors, CANCER, 92(5), 2001, pp. 1156-1167
Citation: Zf. Duan et al., CDNA Technologies and their application to drug resistance research: power, potential and problems, DRUG RESIST, 3(5), 2000, pp. 277-282
Authors:
O'Shea, EM
Lintz, KC
Penson, RT
Seiden, MV
Chabner, BA
Lynch, TJ
Gates, TC
Gallia, KS
Slaby, AE
Brown, JE
Citation: Em. O'Shea et al., When a cancer patient commits suicide: Psychosocial issues faced by patients, families, and caregivers, CANCER PRAC, 8(1), 2000, pp. 5-9
Authors:
Penson, RT
Kronish, K
Duan, Z
Feller, AJ
Stark, P
Cook, SE
Duska, LR
Fuller, AF
Goodman, AK
Nikrui, N
MacNeill, KM
Matulonis, UA
Preffer, FI
Seiden, MV
Citation: Rt. Penson et al., Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel, INT J GYN C, 10(1), 2000, pp. 33-41
Authors:
Feller, AJ
Duan, ZF
Penson, R
Toh, HC
Seiden, MV
Citation: Aj. Feller et al., TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority ofmelanoma cell lines and malignant melanoma, ANTICANC R, 20(6B), 2000, pp. 4147-4151
Authors:
Duska, LR
Penson, R
Supko, JG
Finkelstein, DM
Makastorsis, T
Gallagher, J
Borden, K
Goodman, A
Fuller, AF
Nikrui, N
Seiden, MV
Citation: Lr. Duska et al., A phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer, CLIN CANC R, 5(6), 1999, pp. 1299-1305
Authors:
Duan, ZF
Feller, AJ
Penson, RT
Chabner, BA
Seiden, MV
Citation: Zf. Duan et al., Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype, CLIN CANC R, 5(11), 1999, pp. 3445-3453
Citation: Sl. Mcafee et Mv. Seiden, High dose chemotherapeutic strategies in the treatment of epithelial ovarian carcinoma, CUR OP OBST, 11(1), 1999, pp. 17-21
Citation: Jg. Supko et al., Adaptation of solid phase extraction to an automated column switching method for online sample cleanup as the basis of a facile and sensitive high-performance liquid chromatographic assay for paclitaxel in human plasma, J PHARM B, 21(5), 1999, pp. 1025-1036